Episode

Antibody-Drug Conjugates for Breast Cancer — Proceedings from a San Antonio 2025 Symposium Series

Podcast
Breast Cancer Update
Published
Jan 8, 2026
Duration seconds
5421
Processing state
not_requested
Canonical source
https://breast-oncology.captivate.fm/episode/5647-sanantonioadcsmbc25
Audio
https://dts.podtrac.com/redirect.mp3/episodes.captivate.fm/episode/4dc4914d-2220-476c-9822-a0faa60ccff6.mp3
JSON
/v1/public/podcasts/breast-cancer-update-757579/episodes/antibody-drug-conjugates-for-breast-cancer-proceedings-from-a-san-antonio-2025-symposium-series
Markdown
/podcast/breast-cancer-update-757579/antibody-drug-conjugates-for-breast-cancer-proceedings-from-a-san-antonio-2025-symposium-series.md

Actions

  • POST https://stenobird.com/v1/public/podcasts/breast-cancer-update-757579/episodes/antibody-drug-conjugates-for-breast-cancer-proceedings-from-a-san-antonio-2025-symposium-series/transcription-requests
    Idempotently request low-priority transcript generation for this episode.
  • GET https://stenobird.com/podcast/breast-cancer-update-757579/antibody-drug-conjugates-for-breast-cancer-proceedings-from-a-san-antonio-2025-symposium-series.md
    Read the agent-friendly Markdown representation of this episode resource.

Summary

Dr Javier Cortés from the International Breast Cancer Center in Barcelona, Spain, Dr Rita Nanda from the University of Chicago, Prof Peter Schmid from Barts Cancer Institute in London, United Kingdom, and Dr Priyanka Sharma from the University of Kansas Cancer Center in Westwood discuss key clinical data with antibody-drug conjugates for metastatic breast cancer and their expert perspectives surrounding its clinical applications. CME information and select publications here .